This summer, the chief coding and reimbursement body in the United States will decide whether labs that perform molecular-diagnostic tests will receive a new roster of billing codes, according to a person familiar with the task. If approved, the updated current procedural terminology, or CPT, will likely lower reimbursement hurdles and embolden reference labs to employ more genotyping and gene-expression technologies.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.